US6642397B1
(en)
|
1991-08-28 |
2003-11-04 |
Sterix Limited |
Steroid sulphatase inhibitors
|
EP0982032A2
(en)
*
|
1991-08-29 |
2000-03-01 |
Sterix Limited |
Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
|
AU769753B2
(en)
*
|
1991-08-29 |
2004-02-05 |
Sterix Limited |
Steroid sulphatase inhibitors
|
EP1099706A3
(en)
*
|
1991-08-29 |
2002-09-04 |
Sterix Limited |
Estrane sulphamate derivatives as steroid sulphatase inhibitors
|
EP0928609A2
(en)
*
|
1991-08-29 |
1999-07-14 |
Imperial College Of Science Technology And Medicine |
Use of sulphamate derivatives as steroid sulphatase inhibitors
|
WO1993005064A1
(en)
*
|
1991-08-29 |
1993-03-18 |
Imperial College Of Science, Technology And Medicine |
Steroid sulphatase inhibitors
|
EP0982032A3
(en)
*
|
1991-08-29 |
2002-03-20 |
Sterix Limited |
Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
|
US7098199B2
(en)
|
1991-08-29 |
2006-08-29 |
Sterix Limited |
Steroid sulphatase inhibitors
|
EP1099706A2
(en)
*
|
1991-08-29 |
2001-05-16 |
Sterix Limited |
Estrane sulphamate derivatives as steroid sulphatase inhibitors
|
US6903084B2
(en)
*
|
1991-08-29 |
2005-06-07 |
Sterix Limited |
Steroid sulphatase inhibitors
|
EP0928609A3
(en)
*
|
1991-08-29 |
2001-11-07 |
Sterix Limited |
Use of sulphamate derivatives as steroid sulphatase inhibitors
|
SG73391A1
(en)
*
|
1991-08-29 |
2006-08-30 |
Sterix Ltd |
Steroid sulphatase inhibitors
|
EP0921130A2
(en)
*
|
1991-08-29 |
1999-06-09 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE |
Steroid sulphatase inhibitors
|
EP0921130A3
(en)
*
|
1991-08-29 |
2001-09-05 |
Sterix Limited |
Steroid sulphatase inhibitors
|
CN1057305C
(zh)
*
|
1994-08-09 |
2000-10-11 |
杰纳法姆两合公司 |
雌-1,3,5(10)-三烯衍生物,其制备方法及含有这些化合物的药物组合物
|
WO1996005216A1
(de)
*
|
1994-08-09 |
1996-02-22 |
Jenapharm Gmbh |
Estra-1,3,5(10)-trien-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
|
EP1284273A2
(de)
*
|
1994-08-09 |
2003-02-19 |
JENAPHARM GmbH |
Estra-1,3,5(10)-trien-3-sulfamat Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
EP1284273A3
(de)
*
|
1994-08-09 |
2004-07-21 |
Schering AG |
Estra-1,3,5(10)-trien-3-sulfamat Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
EP1273590A3
(de)
*
|
1994-08-09 |
2004-07-28 |
Schering AG |
Estra- 1,3,5(10)-trien Derivate, Verfahren zu ihrer Herstellung, und diese Ver-bindungen enthaltende pharmazeutische Zusammensetzungen
|
US6841548B2
(en)
*
|
1994-08-09 |
2005-01-11 |
Schering Ag |
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives
|
EP1273590A2
(de)
*
|
1994-08-09 |
2003-01-08 |
Jenapharm GmbH & Co. KG |
Estra- 1,3,5(10)-trien Derivate, Verfahren zu ihrer Herstellung, und diese Ver-bindungen enthaltende pharmazeutische Zusammensetzungen
|
WO1996005217A1
(de)
*
|
1994-08-09 |
1996-02-22 |
Jenapharm Gmbh |
Pharmazeutische zusammensetzungen mit estra-1,3,5(10)-trien-derivaten
|
US6080735A
(en)
*
|
1994-08-09 |
2000-06-27 |
Jenapharm Gmbh & Co. Kg |
Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
|